About: Telehealth in Urology: A Systematic Review of the Literature. How Much Can Telemedicine Be Useful During and After the COVID-19 Pandemic?

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Telehealth in Urology: A Systematic Review of the Literature. How Much Can Telemedicine Be Useful During and After the COVID-19 Pandemic? Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : covidontheweb.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Telehealth in Urology: A Systematic Review of the Literature. How Much Can Telemedicine Be Useful During and After the COVID-19 Pandemic?
Creator	Checcucci, Enrico Esperto, Francesco Giannarini, Gianluca Liguori, Giovanni Novara, Giacomo Porpiglia, Francesco Scarpa, Roberto Abrate, Alberto Bartoletti, Riccardo Crestani, Alessandro De Nunzio, Cosimo Ficarra, Vincenzo Galfano, Antonio Gregori, Andrea Pavan, Nicola Simonato, Alchiede Trombetta, Carlo Tubaro, Andrea
Source	Elsevier; Medline; PMC
abstract	Abstract Context Coronavirus disease 2019 (COVID-19) pandemic has caused increased interest in the application of telehealth to provide care without exposing patients and physicians to the risk of contagion. The urological literature on the topic is sparse. Objective To perform a systematic review of the literature and evaluate all the available studies on urological applications of telehealth. Evidence acquisition After registration on PROSPERO, we searched PubMed and Scopus databases to collect any kind of studies evaluating any telehealth interventions in any urological conditions. The National Toxicology Program/Office of Health Assessment and Translation Risk of Bias Rating Tool for Human and Animal Studies was used to estimate the risk of bias. A narrative synthesis was performed. Evidence synthesis We identified 45 studies (11 concerning prostate cancer [PCa], three hematuria management, six urinary stones, 14 urinary incontinence [UI], five urinary tract infections [UTIs], and six other conditions), including 12 randomized controlled trials. The available literature indicates that telemedicine has been implemented successfully in several common clinical scenarios, including the decision-making process following a diagnosis of nonmetastatic PCa, follow-up care of patients with localized PCa after curative treatments, initial diagnosis of hematuria, management diagnosis and follow-up care of uncomplicated urinary stones and uncomplicated UTIs, and initial evaluation, behavioral therapies, and pelvic floor muscle training in UI patients, as well as follow-up care after surgical treatments of stress urinary incontinence or pelvic organ prolapse. The methodological quality of most of the reports was good. Conclusions Telehealth has been implemented successfully in selected patients with PCa, UI, pelvic organ prolapse, uncomplicated urinary stones, and UTIs. Many urological conditions are suitable for telehealth, but more studies are needed on other highly prevalent urological malignant and benign conditions. Likely, the COVID-19 pandemic will give a significant boost to the use of telemedicine. More robust data on long-term efficacy, safety, and health economics are necessary. Patient summary The diffusion of coronavirus disease 2019 (COVID-19) infections has recently increased the interest in telehealth, which is the adoption of telecommunication to deliver any health care activity. The available literature indicates that telemedicine has been adopted successfully in selected patients with several common clinical urological conditions, including prostate cancer, uncomplicated urinary stones, uncomplicated urinary infections, urinary incontinence, or pelvic organ prolapse. Likely, the COVID-19 pandemic will give a significant boost to the use of telemedicine, but more robust data on long-term efficacy, safety, and costs are necessary.
has issue date	2020-06-18(xsd:dateTime)
bibo:doi	10.1016/j.eururo.2020.06.025
bibo:pmid	32616405
has license	els-covid
sha1sum (hex)	499cfc56678da55af361cefe5c4401abd2d86f4d
schema:url	https://doi.org/10.1016/j.eururo.2020.06.025
resource representing a document's title	Telehealth in Urology: A Systematic Review of the Literature. How Much Can Telemedicine Be Useful During and After the COVID-19 Pandemic?
has PubMed Central identifier	PMC7301090
has PubMed identifier	32616405
schema:publication	Eur Urol
resource representing a document's body	covid:499cfc56678da55af361cefe5c4401abd2d86f4d#body_text
is schema:about of	named entity 'urological' named entity 'During' named entity 'TOPIC' named entity 'PHYSICIANS' named entity 'provide' named entity 'care' named entity 'contagion' named entity 'Pandemic' named entity 'Urinary Tract Infections' named entity 'urine' named entity 'Pelvic floor muscle' named entity 'perinephric' named entity 'urology' named entity 'follow-up' named entity 'e-mail' named entity 'UTIs' named entity 'telehealth' named entity 'quality of life' named entity 'micturition' named entity 'medical subject heading' named entity 'erectile dysfunction' named entity 'systematic review' named entity 'lower urinary tract symptoms' named entity 'VAS score' named entity 'urological conditions' named entity 'clinical pharmacist' named entity 'primary endpoint' named entity 'telehealth' named entity 'upper tract' named entity 'follow-up' named entity 'correlation' named entity 'psychosexual' named entity 'RCT' named entity 'pelvic organ prolapse' named entity 'incontinence' named entity 'calcium' named entity 'telehealth' named entity 'malignancy' named entity 'RCT' named entity 'micturition' named entity 'electronic consultation' named entity 'overactive bladder syndrome' named entity 'comorbidity' named entity 'COVID-19' named entity 'videoconferencing' named entity 'follow-up' named entity 'correlation' named entity 'systematic review' named entity 'telehealth' named entity 'prostate cancer' named entity 'urology' named entity 'medical therapy' named entity 'PubMed' named entity 'metformin' named entity 'follow-up' named entity 'urinary incontinence' named entity 'series 31' named entity 'atmospheric pollutants' named entity 'GEQ' named entity 'care delivery' named entity 'sexual desire' named entity 'Prostate Cancer' named entity 'telemedicine' named entity 'Telemedicine'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software